FindTrial
Sign In

ATG (rabbit)

DRUG3 trials

Sponsors

Northwestern University, St. Jude Children's Research Hospital

Conditions

Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)Hodgkin LymphomaJuvenile Myelomonocytic Leukemia (JMML)Myasthenia GravisMyelodysplastic Syndromes (MDS)NK-Cell Leukemia

Phase 1

Hematopoietic Stem Cell Support in Vasculitis
TerminatedNCT00278512
Northwestern UniversityVasculitis
Start: 2003-08-31End: 2016-06-30Updated: 2018-08-02
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
TerminatedNCT00424489
Northwestern UniversityMyasthenia Gravis
Start: 2002-02-28End: 2016-06-30Updated: 2018-08-31

Phase 2

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
Active, not recruitingNCT03849651
St. Jude Children's Research HospitalAcute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) +5
Start: 2019-01-31End: 2026-06-07Updated: 2026-03-04

Related Papers

Immune reconstitution following memory T-cell add back and prophylactic blinatumomab post TCRαβ/CD19-depleted haploidentical transplantation in pediatric patients with high-risk acute leukemia
Blood2025-11-03
Memory T-Cell Add Back and <i>Prophylactic</i> blinatumomab Post Tcrαβ Depleted Haploidentical Transplantation Results in Promising Outcomes in Pediatric Patients with High-Risk Acute Leukemia
Blood2024-11-05
CD45RO+ T-Cell Add Back and Prophylactic Blinatumomab Administration Post Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia
Blood2021-11-053 citations